Literature DB >> 1384890

[Thyroliberin: new physiological effects and prospects of clinical use].

I P Ashmarin, I E Gurskaia, A A Guseva, T V Lelekova, L Ch Sanzhieva, S A Chepurnov, N E Chepurnova, I I Shimanko, V M Limarev, V V Gavriushov.   

Abstract

In addition to the well-known activities of TRH (stimulation of respiration, antidepressant action, increase of motility, antishock action, therapeutic effects against ataxia, and so forth), some new properties were established. TRH was found (1) to stimulate the contractility of lymph vessels in ultra-low doses and to be useful in the treatment of acute pancreatitis; (2) to normalize cerebral circulation in rats and neonates after asphyxia; (3) to improve the electrophysiological parameters of the retina and pigmented epithelium in rats and man, to exert a long-term positive influence on the health status of patients suffering from senile retinal macular dystrophy; (4) to potentiate the analgesic effect of low doses of morphine in a definite range of doses (analog PR-546). It is of paramount importance that most of the indicated activities of TRH may hold promise for clinical application.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384890

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  1 in total

Review 1.  The effects of ante- and postnatal hypoxia on the central nervous system and their correction with peptide hormones.

Authors:  M V Maslova; A S Maklakova; N A Sokolova; I P Ashmarin; E N Goncharenko; Ya V Krushinskaya
Journal:  Neurosci Behav Physiol       Date:  2003-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.